Peptides studied for sexual desire and arousal via central melanocortin and reproductive-hormone pathways.
Activates central melanocortin pathways that drive desire/arousal; large Phase 3 trials and FDA approval.
Enhances sexual brain processing and reduces aversion via HPG-axis priming, shown in human fMRI studies.
Central MC3R/MC4R agonism promotes arousal — the precursor effect that led to PT-141.
⚠️ Educational research information only — not medical advice. Many peptides are research-use-only and not approved treatments. Always consult a qualified professional.